{"id":"permethrin-1","safety":{"commonSideEffects":[{"rate":"null","effect":"Skin irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Permethrin 1% works by binding to the insect nervous system, causing hyperexcitation and eventual death. This mechanism is specific to the target species and does not affect mammals or other animals in the same way.","oneSentence":"Permethrin 1% acts as an acaricide and insecticide by disrupting the nervous system of insects and arachnids.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:49:38.026Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of head lice and scabies"}]},"trialDetails":[{"nctId":"NCT04332068","phase":"PHASE2","title":"Ivermectin Safety in Small Children","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2023-11-18","conditions":"Scabies","enrollment":240},{"nctId":"NCT05514990","phase":"PHASE1, PHASE2","title":"Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2022-10-07","conditions":"Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma","enrollment":10},{"nctId":"NCT02333799","phase":"PHASE3","title":"A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB","status":"COMPLETED","sponsor":"Global Alliance for TB Drug Development","startDate":"2015-03","conditions":"Pulmonary Tuberculosis","enrollment":109},{"nctId":"NCT06896929","phase":"PHASE2","title":"Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies","status":"NOT_YET_RECRUITING","sponsor":"Children Hospital and Institute of Child Health, Lahore","startDate":"2025-05-01","conditions":"Scabies","enrollment":90},{"nctId":"NCT05565820","phase":"PHASE4","title":"A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation","status":"COMPLETED","sponsor":"Alliance Pharmaceuticals","startDate":"2022-12-15","conditions":"Pediculosis Capitis, Lice Infestations, Head Lice","enrollment":58},{"nctId":"NCT03554616","phase":"NA","title":"Efficacy of Three Novel Bi-treated Long Lasting Insecticidal Nets","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2019-02-01","conditions":"Malaria, Anaemia","enrollment":4200},{"nctId":"NCT04182126","phase":"NA","title":"Adaptive Interventions for Optimizing Malaria Control: a Cluster-Randomized SMART Trial","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2019-12-01","conditions":"LLIN, PBO LLIN, IRS, Larviciding","enrollment":122872},{"nctId":"NCT06396507","phase":"PHASE3","title":"Sulfur vs. Different Regimes of Permethrin for Scabies","status":"COMPLETED","sponsor":"Damascus University","startDate":"2022-03-15","conditions":"Scabies","enrollment":250},{"nctId":"NCT06332872","phase":"PHASE4","title":"Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, Thailand","status":"ACTIVE_NOT_RECRUITING","sponsor":"Phramongkutklao College of Medicine and Hospital","startDate":"2023-12-15","conditions":"Pediculus Capitis Infestation, Permethrin Adverse Reaction, Dimethicone Adverse Reaction","enrollment":117},{"nctId":"NCT01886885","phase":"","title":"Mindfulness Based Chronic Pain Management: A Pilot Study","status":"COMPLETED","sponsor":"University of Utah","startDate":"2013-01","conditions":"Chronic Pain","enrollment":20},{"nctId":"NCT05862701","phase":"PHASE1","title":"Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies","status":"COMPLETED","sponsor":"Combined Military Hospital Abbottabad","startDate":"2022-03-01","conditions":"Scabies","enrollment":60},{"nctId":"NCT02819128","phase":"NA","title":"Investigation of Endemic and Emerging Diseases in Populations of Homeless Households in Marseille.","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2014-01-25","conditions":"Endemic and Emerging Diseases in Populations of Homeless","enrollment":722},{"nctId":"NCT05819983","phase":"PHASE4","title":"Ivermectin/ Permethrin for Scabies","status":"COMPLETED","sponsor":"Universitas Padjadjaran","startDate":"2023-01-25","conditions":"Scabies","enrollment":60},{"nctId":"NCT05378477","phase":"NA","title":"A Clinical Trial to Evaluate Efficacy and Safety of a New Suffocating Head Lice Product.","status":"UNKNOWN","sponsor":"Oystershell NV","startDate":"2022-01-17","conditions":"Head Lice, Pediculosis Capitis","enrollment":220},{"nctId":"NCT05362513","phase":"PHASE1","title":"Comparative Study Between Topical Permethrin 5% and Oral Ivermectin for the Treatment of Scabies","status":"COMPLETED","sponsor":"Combined Military Hospital Abbottabad","startDate":"2021-06-01","conditions":"Scabies","enrollment":100},{"nctId":"NCT05198947","phase":"NA","title":"Better Disease Control by Multidrug Regimen in Scabies","status":"COMPLETED","sponsor":"B.P. Koirala Institute of Health Sciences","startDate":"2017-01","conditions":"Scabies","enrollment":212},{"nctId":"NCT02653898","phase":"PHASE4","title":"Malaria Elimination Pilot Study in Military Forces in Cambodia","status":"UNKNOWN","sponsor":"Armed Forces Research Institute of Medical Sciences, Thailand","startDate":"2016-01","conditions":"Malaria, Parasitic Diseases","enrollment":1050},{"nctId":"NCT03177993","phase":"NA","title":"Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-07-13","conditions":"Lymphatic Filariases, Scabies, Impetigo","enrollment":4773},{"nctId":"NCT02978508","phase":"PHASE3","title":"Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.","status":"COMPLETED","sponsor":"Mayne Pharma International Pty Ltd","startDate":"2016-11","conditions":"Scabies","enrollment":140},{"nctId":"NCT00958139","phase":"PHASE3","title":"Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes","status":"TERMINATED","sponsor":"University of Minnesota","startDate":"2008-06","conditions":"Lyme Disease","enrollment":61},{"nctId":"NCT02775617","phase":"PHASE4","title":"Azithromycin - Ivermectin Mass Drug Administration for Skin Disease","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2016-07","conditions":"Scabies, Yaws, Impetigo","enrollment":1291},{"nctId":"NCT00604084","phase":"NA","title":"Veron Scabies Education and Eradication Program","status":"COMPLETED","sponsor":"Edward Via Virginia College of Osteopathic Medicine","startDate":"2007-05","conditions":"Scabies","enrollment":1057},{"nctId":"NCT03105505","phase":"PHASE4","title":"The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis","status":"UNKNOWN","sponsor":"Barzilai Medical Center","startDate":"2017-04-28","conditions":"Inflammation of the Eyelids","enrollment":75},{"nctId":"NCT02938975","phase":"PHASE3","title":"Field Efficacy Of Insecticide Treated Uniforms And Skin Repellents for Malaria Prevention","status":"UNKNOWN","sponsor":"Ifakara Health Institute","startDate":"2017-11","conditions":"Malaria","enrollment":1500},{"nctId":"NCT02213055","phase":"PHASE2","title":"Pediatric Head Lice Study Product Comparison","status":"COMPLETED","sponsor":"Hackensack Meridian Health","startDate":"2009-05","conditions":"Head Lice","enrollment":97},{"nctId":"NCT02500524","phase":"PHASE3","title":"Cocamide DEA vs Permethrin for Head Lice","status":"TERMINATED","sponsor":"Medical Entomology Centre","startDate":"1998-07","conditions":"Pediculosis Capitis, Head Louse Infestation","enrollment":44},{"nctId":"NCT01514513","phase":"NA","title":"Efficacy and Safety of Licefreee Spray Against Nix 1% Permethrin","status":"COMPLETED","sponsor":"South Florida Family Health and Research Centers","startDate":"2011-08","conditions":"Pediculosis Capitis","enrollment":42},{"nctId":"NCT00927472","phase":"PHASE3","title":"Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2009-08","conditions":"Pediculosis","enrollment":254},{"nctId":"NCT00963508","phase":"PHASE3","title":"Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2009-08","conditions":"Pediculosis","enrollment":403},{"nctId":"NCT00244439","phase":"PHASE3","title":"Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2005-12","conditions":"Lice Infestations","enrollment":360},{"nctId":"NCT00545168","phase":"PHASE3","title":"Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice","status":"COMPLETED","sponsor":"ParaPRO LLC","startDate":"2007-09","conditions":"Pediculus Capitis Infestation","enrollment":480},{"nctId":"NCT00545753","phase":"PHASE3","title":"Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice","status":"COMPLETED","sponsor":"ParaPRO LLC","startDate":"2007-09","conditions":"Pediculosis","enrollment":558},{"nctId":"NCT00857935","phase":"PHASE2","title":"A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse","status":"COMPLETED","sponsor":"ParaPRO LLC","startDate":"2007-03","conditions":"Pediculosis Capitis, Head Lice","enrollment":24},{"nctId":"NCT00672971","phase":"NA","title":"Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice","status":"COMPLETED","sponsor":"Oystershell NV","startDate":"2007-09","conditions":"Head Lice","enrollment":31},{"nctId":"NCT00670514","phase":"NA","title":"Smoking Cessation in a Dentistry Setting","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2003-04","conditions":"Smoking","enrollment":300},{"nctId":"NCT00572884","phase":"NA","title":"Metabolism of the Insecticide Permethrin","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2006-02","conditions":"Pharmacokinetics, Metabolism","enrollment":6}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":71,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NIX Creme Rinse"],"phase":"phase_3","status":"active","brandName":"Permethrin 1%","genericName":"Permethrin 1%","companyName":"ParaPRO LLC","companyId":"parapro-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Permethrin 1% acts as an acaricide and insecticide by disrupting the nervous system of insects and arachnids. Used for Treatment of head lice and scabies.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}